Jibrin A. Kama

The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington's disease

M. DiFiglia, S. Hersch, D. Hoyer, 2010, Molecular Neurodegeneration.

Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1.

A. Young, S. Augood, E. Stern, 2005, Human molecular genetics.